Advert - Proveca
-
Date posted08 August 2019
-
SanctionAdvertisement,
-
Case number/s
For a letter sent to individual pharmacists about the supply of unlicensed and off-label glycopyrronium vs the use of its own product, Sialanar (glycopyrronium bromide), and which could be seen as threatening in tone, Proveca was ruled in breach of the following clauses: Case AUTH/3058/8/18
Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry.
Clause 8.2 - Disparaging the professional opinion of health professionals.
Clause 9.1 - Failing to maintain high standards.
Clause 9.5 - Including a reference to the MHRA when this was not specifically required.